Investigating Keytruda Access Barriers in Guatemala Through Personal Stories
This article details an investigative report by the International Consortium of Investigative Journalists (ICIJ) and Plaza Pública, focusing on the human impact of high cancer drug prices in Latin America. The narrative centers on Francisca Violeta Sam Colop, an Indigenous Maya K’iche’ educator in Guatemala who died after struggling to access Keytruda, a bestselling immunotherapy for advanced melanoma. Despite a court order mandating her insurer cover the treatment, the exorbitant cost—approximately $180,000 annually in Guatemala—posed a fatal barrier. The investigation, part of the 'Cancer Calculus' series, reveals that Keytruda prices vary significantly globally, generating $163 billion for Merck & Co. since 2014. By visiting Sam Colop’s family in Quetzaltenango, journalists uncovered personal realities that legal documents could not capture, illustrating how drug scarcity shapes life-and-death decisions. The report highlights systemic issues in healthcare access, where patients must litigate to receive standard treatments, and underscores the disparity between pharmaceutical profits and patient affordability in lower-income regions.
Wire timeline
Investigating Keytruda Access Barriers in Guatemala Through Personal Stories
This article details an investigative report by the International Consortium of Investigative Journalists (ICIJ) and Plaza Pública, focusing on the human impact of high cancer drug prices in Latin America. The narrative centers on Francisca Violeta Sam Colop, an Indigenous Maya K’iche’ educator in Guatemala who died after struggling to access Keytruda, a bestselling immunotherapy for advanced melanoma. Despite a court order mandating her insurer cover the treatment, the exorbitant cost—approximately $180,000 annually in Guatemala—posed a fatal barrier. The investigation, part of the 'Cancer Calculus' series, reveals that Keytruda prices vary significantly globally, generating $163 billion for Merck & Co. since 2014. By visiting Sam Colop’s family in Quetzaltenango, journalists uncovered personal realities that legal documents could not capture, illustrating how drug scarcity shapes life-and-death decisions. The report highlights systemic issues in healthcare access, where patients must litigate to receive standard treatments, and underscores the disparity between pharmaceutical profits and patient affordability in lower-income regions.
ICIJ